Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cambrex Corp Comments On FY 2013 Revenue Guidance; Issues FY 2013 EBITDA Guidance


Wednesday, 6 Feb 2013 05:05pm EST 

Cambrex Corp announced that for fiscal 2013, it expects sales, excluding the impact of foreign currency, to increase between 8% and 12% over 2012, and EBITDA to be between $62 and $68 million, an increase of 8% to 18% over 2012. 

Company Quote

22.28
-0.49 -2.15%
1:12pm EST